Brief: Marksans Pharma Says US FDA Inspected Goa Manufacturing Facility
18/04/2024 05:40
April 18 (Reuters) - Marksans Pharma Ltd MARK.NS :
* USFDA INSPECTION AT COMPANY'S MANUFACTURING FACILITY IN VERNA, GOA, INDIA
* COMPANY HAS RECEIVED 5 INSPECTIONAL OBSERVATIONS IN FORM 483
* THERE IS NO DATA INTEGRITY OBSERVATION
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg